Site: Ovary
Inclusion Criteria:
Females
No Prior History of Any Cancer
No Report of Bilateral Oophorectomy
Exclude LMPs and Reported Cancers
Matching Factors:
Age at Serum Draw (5 years)
Year of Serum Draw
Match Ratio: 4:1 for general controls, 2:1 for controls who ever had an elevated CA-125, and 2:1 for controls who have a family history of breast or ovarian cancer
Match Technique: Frequency matching only non-cases as controls.
Analytes:
Apolipoprotein A-I
Beta-2-microglobulin
Cancer Antigen 125
Cancer Antigen 15-3
Cancer Antigen 19-9
Cancer Antigen 72-4
Connective Tissue-Activating Peptide III
Eotaxin
Epidermal Growth Factor Receptor
Hepcidin-25
Human Epididymis Protein 4
Insulin-like Growth Factor 2
Insulin-like Growth Factor Binding Protein 2
Inter-alpha-trypsin inhibitor heavy chain H4
Kallikrein-6
Leptin
Macrophage Migration Inhibitory Factor
Matrix Metalloproteinase-3
Matrix Metalloproteinase-7
Mesothelin
Osteopontin
Prolactin
Secretory Leukocyte Protease Inhibitor
Soluble Vascular Cell Adhesion Molecule
Spondin 2
Transferrin
Transthyretin
V-set domain-containing T-cell activation inhibitor 1
Number of Cases: 119
Number of Controls: 952
Site: Ovary
Inclusion Criteria:
Females
No Prior History of Any Cancer
No Report of Bilateral Oophorectomy
Exclude LMPs and Reported Cancers
Matching Factors:
Age at Serum Draw (5 years)
Year of Serum Draw
Match Ratio: 4:1 for general controls, 2:1 for controls who ever had an elevated CA-125, and 2:1 for controls who have a family history of breast or ovarian cancer
Match Technique: Frequency matching only non-cases as controls.
Analytes:
Apolipoprotein A-I
Beta-2-microglobulin
Cancer Antigen 125
Cancer Antigen 15-3
Cancer Antigen 19-9
Cancer Antigen 72-4
Connective Tissue-Activating Peptide III
Eotaxin
Epidermal Growth Factor Receptor
Hepcidin-25
Human Epididymis Protein 4
Insulin-like Growth Factor 2
Insulin-like Growth Factor Binding Protein 2
Inter-alpha-trypsin inhibitor heavy chain H4
Kallikrein-6
Leptin
Macrophage Migration Inhibitory Factor
Matrix Metalloproteinase-3
Matrix Metalloproteinase-7
Mesothelin
Osteopontin
Prolactin
Secretory Leukocyte Protease Inhibitor
Soluble Vascular Cell Adhesion Molecule
Spondin 2
Transferrin
Transthyretin
V-set domain-containing T-cell activation inhibitor 1
Number of Cases: 119
Number of Controls: 952
